Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

41 - 50of 392 News

41 - 50of 392 News

November 19, 2023

Not intended for U.S. and UK Media

OCEANIC-AF study stopped early due to lack of efficacy

November 17, 2023

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer places new bonds with a volume of 5.75 billion U.S. dollars

November 10, 2023

Not intended for U.S. and UK Media

Bayer’s aflibercept 8 mg recommended for approval in EU

November 08, 2023

Bayer Group:

Third quarter below prior year as expected – Group outlook confirmed

October 16, 2023

6th International Rice Congress in Manila, Philippines:

Bayer introduces agricultural system for direct-seeded rice with potential to reduce greenhouse gas emissions and water use by up to 40 percent

October 05, 2023

Not intended for UK Media

Bayer to partner with Twist Bioscience to accelerate drug discovery

September 20, 2023

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues 1.75 billion euro hybrid bond

September 19, 2023

Dr. Jost Reinhard appointed new head of Investor Relations at Bayer

September 18, 2023

Not intended for UK Media

Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator

August 29, 2023

Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn

Inform Yourself on Special Topics

Control Weeds Not Farming

Control Weeds, Not Farming

Farmers discussing their weed management

Everything You Need to Know About Glyphosate

some-bayer-group-headquarters

Managing Glyphosate Litigation

woman harvesting carrots

Managing and Mitigating PCB Litigation Risk